Computing the Structural Dynamics of RVFV L Protein Domain in Aqueous Glycerol Solutions.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
29 09 2021
Historique:
received: 27 07 2021
revised: 24 09 2021
accepted: 25 09 2021
entrez: 23 10 2021
pubmed: 24 10 2021
medline: 19 1 2022
Statut: epublish

Résumé

Many biological and biotechnological processes are controlled by protein-protein and protein-solvent interactions. In order to understand, predict, and optimize such processes, it is important to understand how solvents affect protein structure during protein-solvent interactions. In this study, all-atom molecular dynamics are used to investigate the structural dynamics and energetic properties of a C-terminal domain of the Rift Valley Fever Virus L protein solvated in glycerol and aqueous glycerol solutions in different concentrations by molecular weight. The Generalized Amber Force Field is modified by including restrained electrostatic potential atomic charges for the glycerol molecules. The peptide is considered in detail by monitoring properties like the root-mean-squared deviation, root-mean-squared fluctuation, radius of gyration, hydrodynamic radius, end-to-end distance, solvent-accessible surface area, intra-potential energy, and solvent-peptide interaction energies for hundreds of nanoseconds. Secondary structure analysis is also performed to examine the extent of conformational drift for the individual helices and sheets. We predict that the peptide helices and sheets are maintained only when the modeling strategy considers the solvent with lower glycerol concentration. We also find that the solvent-peptide becomes more cohesive with decreasing glycerol concentrations. The density and radial distribution function of glycerol solvent calculated when modeled with the modified atomic charges show a very good agreement with experimental results and other simulations at 298.15K.

Identifiants

pubmed: 34680060
pii: biom11101427
doi: 10.3390/biom11101427
pmc: PMC8533350
pii:
doi:

Substances chimiques

Peptides 0
Solvents 0
Viral Proteins 0
Water 059QF0KO0R
Glycerol PDC6A3C0OX

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Open Virol J. 2010 Apr 22;4:8-14
pubmed: 20517489
Antiviral Res. 2018 Nov;159:63-67
pubmed: 30261226
Chem Phys Lipids. 2004 Nov;132(1):113-32
pubmed: 15530453
Prog Biophys Mol Biol. 1984;44(2):97-179
pubmed: 6385134
J Chem Theory Comput. 2015 Aug 11;11(8):3696-713
pubmed: 26574453
J Am Chem Soc. 2004 Mar 17;126(10):3291-9
pubmed: 15012160
J Chem Phys. 2007 Jun 21;126(23):235101
pubmed: 17600444
J Chem Theory Comput. 2020 Feb 11;16(2):1284-1299
pubmed: 31877249
Biophys J. 2012 Sep 19;103(6):1354-62
pubmed: 22995508
J Mol Biol. 1992 Aug 5;226(3):775-94
pubmed: 1507226
Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13520-3
pubmed: 9391058
J Chem Phys. 2011 Jan 21;134(3):035104
pubmed: 21261393
Viruses. 2011 May;3(5):493-519
pubmed: 21666766
PLoS Negl Trop Dis. 2014 Apr 10;8(4):e2790
pubmed: 24722586
Cryobiology. 2006 Jun;52(3):323-34
pubmed: 16499898
Curr Opin Virol. 2012 Jun;2(3):315-23
pubmed: 22463980
Proteins. 2007 Jun 1;67(4):931-40
pubmed: 17357162
Cryobiology. 2003 Jun;46(3):205-29
pubmed: 12818211
J Phys Chem B. 2014 Sep 25;118(38):11284-94
pubmed: 25188739
J Mol Biol. 1993 Mar 5;230(1):186-95
pubmed: 8450535
Phys Biol. 2020 Apr 08;17(3):036006
pubmed: 32040946
PLoS Pathog. 2019 May 28;15(5):e1007829
pubmed: 31136637
Biophys J. 2005 May;88(5):3133-46
pubmed: 15731379
Biochim Biophys Acta. 2004 Nov 3;1666(1-2):158-89
pubmed: 15519314
Molecules. 2019 May 07;24(9):
pubmed: 31067727
Comput Chem. 2000 Sep;24(6):693-8
pubmed: 10966127
J Chem Theory Comput. 2013 Jul 9;9(7):3084-95
pubmed: 26583988
J Phys Chem B. 2020 Feb 27;124(8):1424-1437
pubmed: 31999925
J Am Chem Soc. 2010 Jan 27;132(3):1137-43
pubmed: 20047317
Phys Chem Chem Phys. 2011 May 28;13(20):9397-406
pubmed: 21483945
J Phys Chem B. 2015 May 21;119(20):6250-61
pubmed: 25901644
BMC Biol. 2018 Sep 3;16(1):97
pubmed: 30173665
Biophys J. 2017 Aug 8;113(3):550-557
pubmed: 28793210
J Mol Biol. 2002 Feb 8;316(1):101-12
pubmed: 11829506
J Phys Chem A. 2019 Jun 20;123(24):5190-5198
pubmed: 31150239
Curr Opin Struct Biol. 2005 Oct;15(5):586-92
pubmed: 16143512
Biophys J. 1999 May;76(5):2716-26
pubmed: 10233086
Biopolymers. 1983 Dec;22(12):2577-637
pubmed: 6667333
Biochemistry. 1993 Jan 19;32(2):412-20
pubmed: 8422350
Annu Rev Phys Chem. 2013;64:273-93
pubmed: 23298246
Biochemistry. 1981 Aug 4;20(16):4667-76
pubmed: 7295639
Biochemistry. 2009 Nov 24;48(46):11084-96
pubmed: 19817484
J Chem Phys. 2005 Mar 15;122(11):114505
pubmed: 15836227
Acc Chem Res. 2000 Dec;33(12):889-97
pubmed: 11123888
Chem Rev. 2005 Aug;105(8):2999-3093
pubmed: 16092826
Proteins. 2008 Mar;70(4):1235-42
pubmed: 17853448

Auteurs

Gideon K Gogovi (GK)

Department of Mathematics and Statistics, University of Houston-Downtown, Houston, TX 77054, USA.

Swabir Silayi (S)

Office of Research Computing, George Mason University, Fairfax, VA 22030, USA.

Amarda Shehu (A)

Department of Computer Science, George Mason University, Fairfax, VA 22030, USA.
Department of Bioengineering, George Mason University, Fairfax, VA 22030, USA.
School of Systems Biology, George Mason University, Fairfax, VA 22030, USA.
Center for Advancing Human-Machine Partnerships, George Mason University, Fairfax, VA 22030, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH